Sensitivity Analysis: Significant actuarial assumptions for the determination of the defined benefit obligation are discount rate and expected salary increase rate. The effect of change in mortality rate is negligible. Please note that the sensitivity analysis presented below may not be representative of the actual change in the defined benefit obligation as it is unlikely that the change in assumption would occur in isolation of one another as some of the assumptions may be correlated. The results of sensitivity analysis are given below:
Defined Contribution Plans
A Provident Fund for certain eligible employees is administered by the Company through Employees Provident Fund as per the provisions of the Employees’ Provident Funds and Miscellaneous Provisions Act, 1952. The amount contributed is recognized as an expense and included in “Company’s contributions to PF & other funds” of Statement of Profit and Loss account is Rs.25.96 lakhs (LY Rs.30.88 lakhs).
Notes:
(a) The Estimates of future salary increases, considered in actuarial valuation takes account of inflation, seniority, promotion and other relevant factors such as supply and demand in employment market.
(b) Discount rate is based upon the market yields available on Government Bonds at the accounting date with that of liabilities.
NOTE 35 - CONTINGENT LIABILITIES
a) Claims against the company not acknowledged as debt (In lakhs):
• Demand under Central Excise act, 1944 and Finance act, 1944 for the period from 2003 -04, against which appeal was filed before Commissioner appeal- Rs. 17.68 lakhs
• The case of excise pending in Tribunal involving an amount of Rs. 396.34 lakhs against which Rs. 74.34 lakhs paid towards security deposit.
_ui uamn ^
• Cases of sales tax amounting to Rs. 115.42 lakhs are pending before Deputy Commissioner of Commercial Tax
and Rs. 137.04 lakhs from 2005-06 before Joint Commissioner of sales tax._
• In Income tax, an appeal has been filed by the department against relief granted by income tax Appellate Tribunal which is pending in High Court, Calcutta-Rs. 640.78 lakhs for 1988-98. And Rs 316.97 lakhs case is pending before
Commissioner (Appeal) for the period._
. The position of both the units (Hid Road & Budge Budge) has been handed over back to KOPT along with the stocks which are having recoverable value more than the rent payable, Since the matter
is sub judice we have ignored the value of recoverable from the company has provided for rent payable._
. On Account of LC and Bank Guarantee Rs 5,96,63,501/- and 37,87,805/- respectively.
b) Capital and other commitments: Rs. Nil (Previous Year - Rs. Nil)
NOTE 36 - CAPITAL MANAGEMENT
H The Company's objective when managing capital (defined as net debt and equity) are to safeguard the Company's ability to continue as a going concern in order to provide returns to shareholders and benefit for other stakeholders, while protecting and strengthening the balance sheet through the appropriate balance of debt and equity funding. The Company manages its capital structure and makes adjustments to it, in light of changes to economic conditions and strategic objectives of the Company. The Company's capital management, amongst other things, aims to ensure that it meets financial covenants attached to the interest-bearing loans and borrowings that define capital structure requirements. Breaches in meeting the financial covenants would permit the bank to immediately call loans and borrowings. There have been no breaches in the financial covenants of any interest-bearing loans and borrowing in the current period.
NOTE 37
H The charge of dues of IDBI Bank now taken over by Stressed Assets Stabilization Fund (SASF) and WBIDCL has not yet been filed in connection with the satisfaction of charge on ROC portal, despite full and final payment made as per the scheme approved by the Hon’ble Calcutta High Court.
H Since SASF has failed to issue NOC as stipulated in the scheme, the company has filed a petition before the Hon’ble Calcutta High Court on the grounds of breach of terms and conditions of the scheme. The matter is pending before Hon’ble Calcutta High Court. The matter for NOC with WBIDCL is being followed.
Fair Value Hierarchy
The table shown analyses financial instruments carried at fair value. The different levels have been defined below: Level 1: Quoted Prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e.as prices) or indirectly (i.e., derived from prices)
Level 3 : Inputs for the asset or liability that are not based on observable market data (unobservable inputs)
Balance confirmations are matched in respect of trade receivables and trade payables. In the opinion of the management, it is unlikely that there will be any major reconciliation difference with material impact on the carrying amounts of these assets and liabilities as reflected in these financial statements.
NOTE 40B
As per NCLT Order, we purchased RCHEM Industries Pvt. Ltd. In consideration of Rs 3,01,25,000/- but the shares of the Company have not been transferred in the name of ARCL Organics Ltd as on 31/03/2023. So that the M/s RCHEM Industries Pvt. Ltd. is not considered a Subsidiary Company of ARCL Organics Ltd. In this regards the transferred value is shown under Other Current Assets in Note no. -12.
NOTE 41 FINACIAL RISK MANAGEMENT
The Company’s business activities are exposed to a variety of risks including liquidity risk, credit risk, and market risk. The Company seeks to minimize the potential adverse effects of these risks by managing them through a structured process of identification, assessment, and prioritization of risks followed by coordinated efforts to monitor, minimize and mitigate the impact of such risks on its financial performance and capital. For this purpose, the Company has laid comprehensive risk assessment and minimization/mitigation procedures, which are reviewed by the Audit Committee and approved by the Board from time to time. These procedures are reviewed to ensure that executive management controls risks by way of a properly defined framework. The Company does not enter into derivative financial instruments for speculative purposes. The following table explains the sources of risk and how the entity manages the risk in its financial statements. The management reviews the status of all principal risks with a significant potential impact. Additionally, the Audit Committee carried out focused risk reviews of its Plant and divisions. These reviews included an analysis of both the principal risks and the controls, monitoring, and assurance processes established to mitigate those risks to acceptable levels. As a result of these reviews, several actions were identified to continue to improve internal controls and the management of risk.
a) Credit Risk
Credit Risk is the risk that the counterparty will not meet its obligations under a financial instrument or customer contract leading to financial loss. The company is exposed to credit risk from its operating activities (primarily trade receivables and deposits to landlords) and from its financing activities, including deposits with banks and financial institutions, foreign exchange transactions, and other financial instruments. The company generally doesn’t have collateral.
Customer credit risk is managed by business through the company’s established policy, procedures, and controls relating to customer credit risk management. The credit quality of each customer is assessed and credit limits are defined in accordance with this assessment. Outstanding customer receivables and security deposits are regularly monitored.
b) Market Risk
Market risk is the risk that the fair value of future cash flow of financial instruments may fluctuate because of changes in market conditions. Market risk broadly comprises three types of risks namely currency risk, interest rate risk, and price risk (for commodities or equity instruments).
(i) Foreign Exchange Risk - The company operates only in India and has not entered into any foreign exchange or commodity derivative contracts. Accordingly, there is no significant exposure to market risk.
(ii) Interest Rate Risk -As a majority of the financial assets and liabilities of the Company are fixed interestbearing instruments, the Company’s net exposure to interest risk is negligible.
(iii) Security Price Risk -. The company’s exposure to securities price risk arises from investments held by the company and classified in the balance sheet either as fair value through OCI or fair value through Profit or Loss To manage the price risk arising from investments, the company diversifies its portfolio. Diversification of a portfolio is done in accordance with the directions of the Board.
c) Liquidity risk
The company's objective is to at all times maintain the optimum level of liquidity to meet its cash and collateral requirement at all times. The current committed lines of credit are sufficient to meet its short to medium-term expansion needs and hence evaluate the concentration of risk with respect to liquidity as low. The Company monitors rolling forecasts of its liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining headroom on its undrawn committed borrowing facilities at all times so that the Company does not breach borrowing limits or covenants (where applicable) on any of its borrowing facilities.
NOTE -43 EXPENDITURE ON RESEARCH & DEVELOPMENT
During this year company incurred Rs 3,81,463/- for the purchase of Research and Development equipment in Fixed Assets and incurred expenses disclose in Note 26 of Rs 1,00,25,550/-.
(i) Company has used the borrowings from banks and financial institutions for the specific purpose for which it was taken at the balance sheet date.
(ii) No proceedings have been initiated or pending against the company for holding any benami property under the Benami Transactions (Prohibition) Act, 1988 (45 of 1988) and the rules made thereunder and company has not been declared as willful defaulter by and bank or institution or other lender.
(iii) To the best of the information available, the company has not entered into any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act, 1956
(iv) The Company does not have a policy of closing its books on a quarterly basis and preparing quarterly financials
(v) Company has not traded or invested in Crypto currency or Virtual Currency during the financial year
vi) The Company has not received any fund from any person(s) or entity(ies), including foreign entities ("Funding party") with the understanding (whether recorded in writing or otherwise) that the Company shall directly or indirectly lend or invest in other persons or entities indentified in any manner whatsoever by or on behalf of the Funding party (ultimate beneficiaries); or provide any guarantee, security or the like on behalf of the ultimate beneficiaries.
vii) No funds (which are material either individually or in the aggregate) have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entity (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;
NOTE 46 - SEGMENT REPORTING TO BE INCLUDED BY UPDATING THE BELOW LANGUAGE
The Company is engaged in the business of manufacturing and selling Phenolics, Amino Resins, Melamine Resins and Formaldehyde. Based on the nature of products, production process, regulatory environment, customers and distribution methods there are no reportable segment(s) other than "'Chemicals and Allied Products'"
|